NCT01376232View on ClinicalTrials.gov

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

November 8, 2010

Primary Completion Date

December 20, 2010

Study Completion Date

December 20, 2010

Conditions

Anaemia

Interventions

DRUG

GSK1278863

GSk1278863 100mg

DRUG

GSK1278863 + food

High Fat meal + 100 mg GSK1278863

DRUG

Gemfibrozil

600 mg Gemfibrozil

Trial Locations (1)

560100

GSK Investigational Site, Electronics City, Bengalore

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

collaborator

Octagon Research Solutions, Incoporated

UNKNOWN

lead

GlaxoSmithKline

INDUSTRY